Prostate cancer: is androgen-deprivation therapy chosen wisely?
- PMID: 25073003
- DOI: 10.1038/nrclinonc.2014.130
Prostate cancer: is androgen-deprivation therapy chosen wisely?
Comment on
-
Fifteen-year survival outcomes following primary androgen-deprivation therapy for localized prostate cancer.JAMA Intern Med. 2014 Sep;174(9):1460-7. doi: 10.1001/jamainternmed.2014.3028. JAMA Intern Med. 2014. PMID: 25023796 Free PMC article.
References
-
- JAMA Intern Med. 2014 Sep;174(9):1460-7 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
